Loading…
avatar for Michael Blum

Michael Blum

FDA, United States
Deputy Director, Office of Pharmacovigilance and Epidemiology, CDER
Michael Blum, MD, MPH is currently Deputy Director, Office of Pharmacovigilance and Epidemiology in FDA CDER. He is a pediatric infectious diseases specialist. Dr. Blum worked as a medical reviewer in the CDER Division of Anti-Infective Drug Products, followed by over 20 years in the pharmaceutical industry in a variety of vaccine and safety leadership positions. He has experience in industry and the FDA with the use of real-world data to assess the safety of drugs and biologics.
  • Timezone
  • Filter By Date DIA 2021 Virtual Global Annual Meeting Jun 1 -Jul 1, 2021
    • June 2021
      SunMonTueWedThuFriSat
       12345
      6789101112
      13141516171819
      20212223242526
      27282930 
      July 2021
      SunMonTueWedThuFriSat
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
  • Filter By Venue Virtual Meeting
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Featured Topics